We're proud to announce that we've been chosen to be a provider for VYLOY (zolbetuximab-clzb). This new treatment for stomach cancer and gastroesophageal junction (GEJ) cancer kills cancer cells and slows tumor growth. We're proud to partner with Astellas Pharma to provide this new first-line treatment! You can find our full drug inventory here: https://lnkd.in/ggbF7mYa #CancerTreatment #StomachCancer #HealthcareInnovation
